Aptamer Group PLC
F:P0J
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aptamer Group PLC
F:P0J
|
UK |
|
IMI PLC
LSE:IMI
|
UK |
|
SIG Group AG
SIX:SIGN
|
CH |
|
A
|
Alkane Resources Ltd
XMUN:AK7
|
AU |
|
L
|
Linde PLC
DUS:LIN
|
UK |
Intrinsic Value
Is P0J undervalued or overvalued?
See the intrinsic value estimate for Aptamer Group PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
P0J looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with P0J’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Aptamer Group Does
Aptamer Group PLC develops aptamers, which are short synthetic molecules that can bind to a target in a very specific way, much like an antibody does. The company sells aptamer discovery and development services to life science, diagnostic, and pharmaceutical customers who need custom binding molecules for tests, research tools, or therapeutic programs.
- Headquarters
- United Kingdom UK
- Employees
- 30
- IPO date
- Dec 22, 2021
Earnings Waterfall
Aptamer Group PLC
The intrinsic value for Aptamer Group PLC (P0J) under the Base Case is hidden EUR.
Compared with the current market price of 0.0005 EUR, the stock appears hidden.